News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
229 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32753)
Month
January (2936)
February (2969)
March (2710)
April (2907)
May (3626)
June (2409)
July (2088)
August (2589)
September (2381)
October (3064)
November (3190)
December (1884)
Day
2 (21)
3 (149)
4 (290)
5 (296)
6 (241)
7 (145)
10 (297)
11 (166)
12 (61)
13 (229)
14 (184)
17 (126)
18 (144)
19 (137)
20 (141)
21 (143)
24 (150)
25 (65)
26 (125)
27 (69)
28 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
FDA
FDA Action Alert: BMS, Bayer, Arrowhead and More
One of the FDA’s potential approvals this month could break an existing monopoly in the treatment space for a rare growth disorder.
November 13, 2025
·
5 min read
·
Tristan Manalac
Mergers & acquisitions
Pfizer Closes Metsera Deal, Officially Ending Bidding War Drama
Speaking at a conference this morning, Pfizer CEO Albert Bourla suggested that Metsera’s therapies could begin hitting the market in 2028.
November 13, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 13, 2025
·
16 min read
Press Releases
Ascendis Pharma Reports Third Quarter 2025 Financial Results
November 13, 2025
·
13 min read
Press Releases
Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025
·
9 min read
Press Releases
Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results
November 13, 2025
·
11 min read
Press Releases
NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises
November 13, 2025
·
9 min read
Press Releases
Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
November 13, 2025
·
17 min read
Press Releases
Erasca Reports Third Quarter 2025 Business Updates and Financial Results
November 13, 2025
·
8 min read
Press Releases
MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress
November 13, 2025
·
13 min read
Previous
2 of 23
Next
